UnitedHealth and its pharmacy benefit manager OptumRx are being sued by an independent pharmacy for allegedly strong-arming pharmacies into agreeing to “unconscionable” performance-based fees, ...

CHICAGO-- (BUSINESS WIRE)--OptumRx is becoming the first major pharmacy care services company to introduce fully sustainable medication packaging that replaces polystyrene, or foam. The new packaging ...

OptumRx has to repay the state $15 million in prescription-drug overcharges assessed to the Ohio Bureau of Workers’ Compensation (BWC) under an agreement announced today by Ohio Attorney General Dave ...

For years, drug prices have been on the rise, leaving as many as 18 million Americans struggling to pay for necessary prescriptions. A drug pricing provision of the Build Back Better Act, which passed ...

NEW YORK--(BUSINESS WIRE)--Optum announced the completion of its combination with Catamaran Corporation (NASDAQ: CTRX) (TSX: CCT). Catamaran and Optum’s pharmacy care services business, OptumRx, are ...

OptumRx, Optum’s pharmacy benefit management company, has agreed to pay $20 million to settle allegations it improperly filled certain opioid prescriptions, violating the Controlled Substances Act.

OptumRx specializes in the delivery, clinical management and affordability of prescription medications and consumer health products. Our high-quality, integrated services deliver optimal member ...

UnitedHealth Group's Q1 earnings highlight OptumRx's exceptional performance and its growing significance in the company's financials. OptumRx is utilizing big data analytics to unlock efficiencies, ...

CVS Health is partnering with UnitedHealth's pharmacy benefit manager business OptumRx in a move that helps the retailer compete with rival drugstore chain Walgreens, which struck a similar deal with ...

UnitedHealth Group (NYSE: UNH) is the largest health insurance company in the United States with consolidated revenue of $226 billion in 2018. It provides individual insurance, employer sponsored ...

As 2023 draws to a close, pressure has been heating up on PBMs over their business practices, including from Congress, the CMS and antitrust agencies. The drug middlemen are also facing lawsuits from ...